Adam Wilkinson

Company: Microbiotica

Job title: Pre-Clinical Development

Seminars:

A Clinically-Defined Multifunctional Bacterial Consortium for the Treatment of Ulcerative Colitis 11:50 am

Microbiotica possesses a unique analysis platform for the discovery of microbiome signatures from clinical data Leveraging the power of the Microbiotica platform to analyse a unique FMT trial dataset in mild-to-moderate UC patients, a response signature has been identified for development into a multi-species consortium product – MB310 MB310 addresses multiple aspects of UC disease…Read more

day: Track B - Afternoon - Day One